2022
29 Mar 2022
Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts
IDTechEx Report: Andy Ko
2021
29 Oct 2021
BluSense
BluSense Diagnostics is an in vitro diagnostics company with core technology in microfluidics and immuno-magnetic assays for point-of-care testing of infectious diseases. IDTechEx analyst Andy Ko spoke with BluSense CEO Maarten van der Linden and CSO Dr Marco Donolato on 29/10/2021.
Included are:
